Source: Annual Congress 2006 - Respiratory function assessment



Rating:

Share or cite this content

Citations should be made in the following way:
E. Kunter, A. Yonem, E. Solmazgul, Z. Kartaloglu, M. Ozata (Istanbul, Turkey). The effect of androgen replacement treatment on pulmonary functions in male patients with hypogonadism. Eur Respir J 2006; 28: Suppl. 50, 4963

Member's Comments

No comment yet.

Related content which might interest you: The effects of hormone replacement therapy on pulmonary function in postmenopausal women Source: Eur Respir J 2004; 24: Suppl. 48, 574s Year: 2004 The effects of hormone therapy on pulmonary function tests in postmenopausal women Source: Eur Respir J 2004; 24: Suppl. 48, 573s Year: 2004 Biomarker-high patients and steroid responsiveness Source: International Congress 2018 – PG17 Asthma phenotyping Year: 2018 Using hormone replacement therapy in perimenopausal women with bronchial asthma (BA) Source: Annual Congress 2007 - Novel issues in the treatment and control of asthma Year: 2007 The influence of glucocorticoid therapy on the level of sex hormones in menopausal women with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 51s Year: 2002 Hormone replacement therapy may preserve lung function during reproductive aging Source: International Congress 2017 – Factors associated with lung function development Year: 2017 Serum sex hormone levels in COPD patients and its relation with hypoxaemia and pulmonary functions Source: Eur Respir J 2001; 18: Suppl. 33, 213s Year: 2001 The effect of augmentation therapy on systemic and pulmonary inflammation markers in α1-antitrypsin deficiency patients Source: Annual Congress 2010 - Recent developments of molecular pathology and functional genomics in non-neoplastic and neoplastic lung diseases Year: 2010 The correlation between level of women sexual hormones and lung function parameters in patients with COPD Source: Annual Congress 2008 - Biomarkers and disease assessment in COPD Year: 2008 Effect of augmentation therapy on immune function of patients with severe Alpha1-antitrypsin deficiency Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012 The effects of hormone replacement therapy on airway function,skin tests to allergens and serum ECP levels in postmenopausal women Source: Eur Respir J 2002; 20: Suppl. 38, 425s Year: 2002 Hormone replacement therapy associated with improved oxygenation in women with IPF Source: Annual Congress 2010 - Different patterns of diffuse parenchymal lung disease Year: 2010 Women receiving hormone replacement therapy are at high risk of developing asthma Source: Virtual Congress 2020 – Comorbidities/multimorbidites and mortality in patients with chronic lung diseases Year: 2020 COPD patients with hypogonadism are more hypoxic and hypercapnic during exacerbation than patients with normal testosterone level Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 Glucocorticoid-induced adrenal suppression and metabolic syndrome in glucocorticoid treated AECOPD patients related to different gene polymorphisms of the glucocorticoid receptor gene Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 The effect of antituberculosis chemotherapy on thyroid hormones in active pulmonary tuberculosis patients Source: Eur Respir J 2001; 18: Suppl. 33, 306s Year: 2001 Characteristics of glucose metabolism in patients receiving glucocorticoid therapy for interstitial lung disease. Source: International Congress 2017 – Miscellaneous clinical problems Year: 2017 Effect of long-term specific therapy in a cohort of 33 patients with pulmonary arterial hypertension of various etiologies Source: Annual Congress 2010 - Pulmonary circulation II Year: 2010 Effect of systemic steroid treatment on serum leptin levels in patients with COPD exacerbation Source: Eur Respir J 2005; 26: Suppl. 49, 284s Year: 2005 Endocrinological disturbances in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 76S-80S Year: 2003